Name (Synonyms) | Correlation | |
---|---|---|
drug2818 | famotidine Wiki | 1.00 |
drug301 | BMS-986322 Wiki | 1.00 |
drug302 | BMS-986322 Placebo Wiki | 1.00 |
drug726 | Data record Wiki | 0.71 |
Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Pancreatic adenocarcinoma will be the 2nd cause of death by cancer in Europe in 2030. Pancreatic adenocarcinoma has poor prognosis with an all-stages combined 5-year survival rate below 8%. Since December 2019, a new coronavirus (Severe Acute Respiratory Syndrome Corona Virus 2, SARS-CoV-2) is responsible of COVID-19 infection with potentially severe respiratory syndrome or even multi-organ failure. An increased risk of severe COVID-19 infection in cancer patients is suggested in several Chinese series. Cancer care structures quickly reorganized to limit high-risk situations (diagnostic procedure, major surgery, cytotoxic poly-chemotherapy) and use alternatives such as on-hold chemotherapy. These reorganizations could be associated with a loss of chance for pancreatic adenocarcinoma.
Description: curative surgery (with or without chemotherapy), chemotherapy only or exclusive supportive care
Measure: Pancreatic adenocarcinoma treatment Time: 6 months